Experiences of Patients With Chronic Obstructive Pulmonary Disease Using the Apple Watch Series 6 Versus the Traditional Finger Pulse Oximeter for Home SpO2 Self-Monitoring: Qualitative Study Part 2.

Autor: Liu Y; Ingram School of Nursing, McGill University, Montreal, QC, Canada., Arnaert A; Ingram School of Nursing, McGill University, Montreal, QC, Canada., da Costa D; Ingram School of Nursing, McGill University, Montreal, QC, Canada., Sumbly P; Ingram School of Nursing, McGill University, Montreal, QC, Canada., Debe Z; Ingram School of Nursing, McGill University, Montreal, QC, Canada., Charbonneau S; Academic Affairs, Teaching and Research Directorate, Montreal West Island Integrated University Health and Social Service Centre, Montreal, QC, Canada.
Jazyk: angličtina
Zdroj: JMIR aging [JMIR Aging] 2023 Nov 02; Vol. 6, pp. e41539. Date of Electronic Publication: 2023 Nov 02.
DOI: 10.2196/41539
Abstrakt: Background: Amid the rise in mobile health, the Apple Watch now has the capability to measure peripheral blood oxygen saturation (SpO 2 ). Although the company indicated that the Watch is not a medical device, evidence suggests that SpO 2 measurements among patients with chronic obstructive pulmonary disease (COPD) are accurate in controlled settings. Yet, to our knowledge, the SpO 2 function has not been validated for patients with COPD in naturalistic settings.
Objective: This qualitative study explored the experiences of patients with COPD using the Apple Watch Series 6 versus a traditional finger pulse oximeter for home SpO 2 self-monitoring.
Methods: We conducted individual semistructured interviews with 8 female and 2 male participants with moderate to severe COPD, and transcripts were qualitatively analyzed. All received a watch to monitor their SpO 2 for 5 months.
Results: Due to respiratory distress, the watch was unable to collect reliable SpO 2 measurements, as it requires the patient to remain in a stable position. However, despite the physical limitations and lack of reliable SpO 2 values, participants expressed a preference toward the watch. Moreover, participants' health needs and their unique accessibility experiences influenced which device was more appropriate for self-monitoring purposes. Overall, all shared the perceived importance of prioritizing their physical COPD symptoms over device selection to manage their disease.
Conclusions: Differing results between participant preferences and smartwatch limitations warrant further investigation into the reliability and accuracy of the SpO 2 function of the watch and the balance among self-management, medical judgment, and dependence on self-monitoring technology.
(©Yuxin Liu, Antonia Arnaert, Daniel da Costa, Pia Sumbly, Zoumanan Debe, Sylvain Charbonneau. Originally published in JMIR Aging (https://aging.jmir.org), 02.11.2023.)
Databáze: MEDLINE